Draeger Altan Correction Cites Mechanical Ventilation Failure

The recall, recently deemed FDA Class I, refers to the company’s Atlan A350 and A350 XL anesthesia workstations.

Katie Hobbins, Managing Editor

November 22, 2024

1 Min Read
Atlan anesthesia workstations
Image courtesy of Draeger

Draeger’s correction of its Atlan A350 and A350 XL anesthesia workstations were recently deemed Class I by FDA. The correction pertains to the potential of the device to experience a mechanical ventilation failure.

The Atlan A350 and A350 XL anesthesia workstations are used in anesthetizing adults, children, and neonates and can be used for automatic and manual ventilation, pressure-supported spontaneous breathing, and spontaneous breathing, according to the company. The workstation is intended to be used for inhaled anesthesia during surgical or diagnostic procedures.

Draeger is correcting the workstations after finding a manufacturing error that could cause the piston ventilator to fail before use or mechanical ventilation to fail during use.

If failure were to occur, it could result in hypoxia, lung recruitment, bradycardia, cardiac arrest, and death. Currently, there’s been no injuries or deaths connected to the issue.

Contacting affected customers on Oct. 15, Draeger said a representative will be in contact to arrange for a ventilator motor assembly replacement. Until replaced, however, the company said to continue to use the devices under permanent supervision, and, if the mechanical ventilation fails, use Man/Spont ventilation mode to ventilate patients as needed and monitor patient’s oxygenation status as “a brief cessation of ventilation can potentially lead to injury,” according to the recall notice.

Related:Baxter Corrects MiniCap Extended Life PD Transfer Sets Due to Toxic Compound Exposure Risk

Additionally, Draeger said healthcare providers can downgrade the alarm priority of “ventilator error” to “alarm reset” after switching to the Man/Spont ventilation mode.

About the Author

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like